secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2025-12-31T23:59:59+00:00
Accession:  0001104659-25-125420
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics shareholders elect all six director nominees and ratify KPMG as auditor
--------------------------------------------------------------------------------

- All six director nominees elected: Jay Kranzler, Faith Charles, Neil Herskowitz, Alexandra MacLean, Curtis Oltmans, Lindsay Rosenwald.
- Ratification of KPMG LLP as independent auditor for FY 2025 passed with 3,862,335 votes for, 104,651 against.
- Annual meeting held December 30, 2025; record date November 25, 2025; 3,183,426 common shares and 250,000 Class A Preferred shares eligible.
- Broker non-votes: 0 on director election; all votes cast on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465925125420/0001104659-25-125420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465925125420/tm2534543d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-125420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer